Literature DB >> 30479740

Strategies to promote public engagement around deprescribing.

Justin P Turner1, Janet Currie2, Johanna Trimble3, Cara Tannenbaum4.   

Abstract

Many seniors remain unaware that certain medications may be harmful, despite high rates of polypharmacy and inappropriate medication use among community-dwelling older adults. Patient education is an effective method for reducing the use of inappropriate medications. Increasing public awareness and engagement is essential for promoting shared decision-making to deprescribe. The Canadian Deprescribing Network was created to address the lack of a systematic pan-Canadian initiative to implement deprescribing among older Canadians. The Canadian Deprescribing Network deliberately included patient advocates in its organization from the outset, in order to ensure a key strategic focus on public awareness and education. In this paper, we present the processes and activities rolled out by the Canadian Deprescribing Network as a blueprint model for engaging the public on deprescribing. Embedded within the structure of the network, the subcommittee on public awareness and engagement implements an action plan that includes needs assessments, population surveys, focus groups, deprescribing fairs, national stakeholders' meetings, public lectures and monthly exchanges with community champions and seniors' organizations. Educational materials and online media have been developed based on the answers to the questions: what information do seniors need about deprescribing? who should this information be delivered to? who needs to deliver the message? and how should seniors be engaged in deprescribing? In conjunction with seniors' organizations, members of the Network have iteratively refined key deprescribing messages, disseminated information about deprescribing, engaged the press and created a grass roots-driven public awareness and education campaign across Canada. Over 3000 seniors and seniors' organizations are involved, with over 25,000 educational tools being distributed across the country.

Entities:  

Keywords:  aged; community participation; consumer advocacy; deprescribing; education; public health professional

Year:  2018        PMID: 30479740      PMCID: PMC6243424          DOI: 10.1177/2042098618794165

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  23 in total

1.  American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2015-10-08       Impact factor: 5.562

2.  Should Canada allow direct-to-consumer advertising of prescription drugs?: no.

Authors:  Barbara Mintzes
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

3.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

4.  A guide to scaling up population health interventions.

Authors:  Andrew J Milat; Robyn Newson; Lesley King; Chris Rissel; Luke Wolfenden; Adrian Bauman; Sally Redman; Michael Giffin
Journal:  Public Health Res Pract       Date:  2016-01-28

5.  Effect of age, education and health status on community dwelling older men's health concerns.

Authors:  Cara Tannenbaum
Journal:  Aging Male       Date:  2011-11-21       Impact factor: 5.892

6.  Medication use and risk of falls.

Authors:  C Ineke Neutel; Sheril Perry; Colleen Maxwell
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-03       Impact factor: 2.890

7.  Polypharmacy cut-points in older people with cancer: how many medications are too many?

Authors:  Justin P Turner; Kris M Jamsen; Sepehr Shakib; Nimit Singhal; Robert Prowse; J Simon Bell
Journal:  Support Care Cancer       Date:  2015-10-09       Impact factor: 3.603

8.  Association of polypharmacy with fall-related fractures in older Taiwanese people: age- and gender-specific analyses.

Authors:  Hsueh-Hsing Pan; Chung-Yi Li; Tzeng-Ji Chen; Tung-Ping Su; Kwua-Yun Wang
Journal:  BMJ Open       Date:  2014-03-28       Impact factor: 2.692

9.  A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.

Authors:  Philippe Martin; Cara Tannenbaum
Journal:  BMJ Open       Date:  2017-05-04       Impact factor: 2.692

10.  SUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking.

Authors:  Andrew D Oxman; Simon Lewin; John N Lavis; Atle Fretheim
Journal:  Health Res Policy Syst       Date:  2009-12-16
View more
  2 in total

Review 1.  Deprescribing practices in Canada: A scoping review.

Authors:  Mansi Desai; Tanya Park
Journal:  Can Pharm J (Ott)       Date:  2022-08-17

2.  Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use.

Authors:  Dee Mangin; Doron Garfinkel
Journal:  Ther Adv Drug Saf       Date:  2019-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.